Back to Search Start Over

Approaches to Treating NF1 Tibial Pseudarthrosis

Authors :
B. Stephens Richards
Deborah M. Eastwood
Elizabeth K. Schorry
Mateusz Kolanczyk
Kim Hunter-Schaedle
Linlea Armstrong
David Wilkes
Feng Chun Yang
Gloria Gutierrez
David G. Little
Matthew E. Oetgen
Fergal Monsell
Florent Elefteriou
Tiziana Greggi
Aaron Schindeler
David L. Kendler
David Viskochil
David A. Stevenson
Alvin H. Crawford
Jan M. Friedman
Source :
Journal of Pediatric Orthopaedics. 33:269-275
Publication Year :
2013
Publisher :
Ovid Technologies (Wolters Kluwer Health), 2013.

Abstract

Background Neurofibromatosis 1 (NF1) is an autosomal dominant disorder with various skeletal abnormalities occurring as part of a complex phenotype. Tibial dysplasia, which typically presents as anterolateral bowing of the leg with subsequent fracture and nonunion (pseudarthrosis), is a serious but infrequent osseous manifestation of NF1. Over the past several years, results from clinical and experimental studies have advanced our knowledge of the role of NF1 in bone. On the basis of current knowledge, we propose a number of concepts to consider as a theoretical approach to the optimal management of tibial pseudarthrosis. Methods A literature review for both clinical treatment and preclinical models for tibial dysplasia in NF1 was performed. Concepts were discussed and developed by experts who participated in the Children's Tumor Foundation sponsored International Bone Abnormalities Consortium meeting in 2011. Results Concepts for a theoretical approach to treating tibial pseudarthrosis include: bone fixation appropriate to achieve stability in any given case; debridement of the "fibrous pseudarthrosis tissue" between the bone segments associated with the pseudarthrosis; creating a healthy vascular bed for bone repair; promoting osteogenesis; controlling overactive bone resorption (catabolism); prevention of recurrence of the "fibrous pseudarthrosis tissue"; and achievement of long-term bone health to prevent recurrence. Conclusions Clinical trials are needed to assess effectiveness of the wide variation of surgical and pharmacologic approaches currently in practice for the treatment of tibial pseudarthrosis in NF1. Level of evidence Level V, expert opinion.

Details

ISSN :
02716798
Volume :
33
Database :
OpenAIRE
Journal :
Journal of Pediatric Orthopaedics
Accession number :
edsair.doi.dedup.....f95f36f8e38e950390c06f0e3025a479
Full Text :
https://doi.org/10.1097/bpo.0b013e31828121b8